Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1611-1620 of 2862 for cancer

Edit search filters
  1. A Study Of Preventive Treatment Of Oxaliplatin Induced Peripheral Neuropathy In Metastatic Colorectal Cancer (POLAR-M)

    La Crosse, WI

  2. Individualizing Approaches To Surveillance Mammography In Older Breast Cancer Survivors - The I-MAMMO Study

    Rochester, MN

  3. A Study Of BBI608 In Combination With Standard Chemotherapies In Adult Patients With Advanced Gastrointestinal Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

  4. A Study Of Pembrolizumab Alone As Therapy For Metastatic Triple-Negative Breast Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  5. Hyperthermic Chemotherapy For Gastric Cancer At High Risk Of Peritoneal Recurrence

    Rochester, MN

  6. Docetaxel And Cyclophosphamide Compared To Anthracycline-Based Chemotherapy In Treating Women With HER2-Negative Breast Cancer

    Rochester, MN

  7. Phase IIB/III Of TG4010 Immunotherapy In Patients With Stage IV Non-Small Cell Lung Cancer

    Scottsdale/Phoenix, AZ

  8. Ruxolitinib In Combination With Pemetrexed/Cisplatin In Non Small Cell Lung Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

  9. Phase I Dose Escalation Study For BAY 1251152 In Patients With Advanced Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  10. A Study Comparing The Outcomes Of Observation Versus Immediate Surgery For Low Risk Bladder Cancer

    Rochester, MN

.

Mayo Clinic Footer